Categories
Research Insights
NIH: Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
This program intends to fund interdisciplinary teams focusing on innovative medicinal chemistry, chemical biology and chemoproteomic approaches to target fusion oncoprotein-driven cancers. The goal is to accelerate innovative drug discovery focused on developing small molecules to effectively disrupt fusion oncoproteins.
Amount: $11,325,000
Due Date: 10/15/23 (LOI); 11/15/23 (Full Proposal)